Sano, M., Takei, M., Shiraishi, Y., & Suzuki, Y. (2016). Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys. J Clin Med Res.
Chicago Style CitationSano, Motoaki, Makoto Takei, Yasuyuki Shiraishi, i Yoshihiko Suzuki. "Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys." J Clin Med Res 2016.
Cita MLASano, Motoaki, Makoto Takei, Yasuyuki Shiraishi, i Yoshihiko Suzuki. "Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys." J Clin Med Res 2016.
Atenció: Aquestes cites poden no estar 100% correctes.